Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor
Drug resistance presents one of the major causes for the failure of cancer chemotherapy. Cancer stem-like cells (CSCs), a population of self-renewal cells with high tumorigenicity and innate chemoresistance, can survive conventional chemotherapy and generate increased resistance. Here, we develop a...
Saved in:
Main Authors: | Shiyang Shen (Author), Teng Li (Author), Jinyi Fan (Author), Quanlin Shao (Author), He Dong (Author), Xiao Xu (Author), Ran Mo (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Advancement and Patents of the Lipid Polymer Hybrid Nanoparticles
by: Naman Krishna Kasera, et al.
Published: (2016) -
Development of Lipid-Polymer Hybrid Nanoparticles for Improving Oral Absorption of Enoxaparin
by: Bo Tang, et al.
Published: (2020) -
Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization
by: Seyedeh Negin Kassaee, et al.
Published: (2024) -
Pulmonary delivery of siRNA-loaded lipid-polymer hybrid nanoparticles: Effect of nanoparticle size
by: Abishek Wadhwa, et al.
Published: (2023) -
Cartilage‐targeting ultrasmall lipid‐polymer hybrid nanoparticles for the prevention of cartilage degradation
by: Xiangzhao Ai, et al.
Published: (2021)